BLPH logo

Bellerophon Therapeutics (BLPH) EBITDA

Annual EBITDA

-$22.32 M
-$2.26 M-11.27%

December 31, 2022

Summary

Performance

1-Year Change

-11.27%

3-Year Change

-30.33%

5-Year Change

+7.87%

15-Year Change

+7.87%

BLPH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$17.13 M

3-Year Low

-$22.32 M
BLPH annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLPH previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLPH next annual earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

Annual Revenue

-
BLPH annual revenue value is unknown

Annual Net Income

-$19.83 M
BLPH annual net profit is -$19.83 million

Annual EBIT

-$22.38 M
BLPH annual earnings before interest & taxes is -$22.38 million

Annual EPS

-$2.08
BLPH annual earnings per share is -$2.08

Quarterly EBITDA

-$2.17 M
+$3.09 M+58.73%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+57.41%

3-Year Change

+57.41%

5-Year Change

+67.81%

BLPH Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.48 M
BLPH quarterly EBITDA is currently -246.62% below its historical high of $1.48 million

3-Year Low

-$6.52 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

Quarterly Revenue

-
BLPH quarterly revenue value is unknown

Quarterly Net Income

-$1.92 M
BLPH quarterly net profit is -$1.92 million

Quarterly EBIT

-$2.17 M
BLPH quarterly earnings before interest & taxes is -$2.17 million

Quarterly EPS

-$0.16
BLPH quarterly earnings per share is -$0.16

TTM EBITDA

-$11.03 M
+$2.92 M+20.96%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+48.68%

3-Year Change

+48.68%

5-Year Change

+48.68%

BLPH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$11.03 M
BLPH TTM EBITDA is currently at an all-time high

3-Year Low

-$22.32 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

TTM Revenue

-
BLPH TTM revenue value is unknown

TTM Net Income

-$9.25 M
BLPH TTM net profit is -$9.25 million

TTM EBIT

-$11.04 M
BLPH TTM earnings before interest & taxes is -$11.04 million

TTM EPS

-$0.84
BLPH TTM earnings per share is -$0.84

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$22.32 M
BLPH annual EBITDA is -$22.32 million

Annual Net Income

-$19.83 M
BLPH annual net profit is -$19.83 million

Annual Interest Expense

-
BLPH annual interest expense value is unknown

Annual Income Tax

-$2.42 M
BLPH annual income tax is -$2.42 million

Annual D&A

$65.00 K
BLPH annual depreciation & amortization is $65.00 thousand

BLPH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.3%+57.4%+48.7%
3 y3 years-30.3%+57.4%+48.7%
5 y5 years+7.9%+67.8%+48.7%

BLPH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+11.3%at low-246.6%+200.6%at high+102.4%
5 y5-year+30.3%+17.1%-246.6%+279.3%at high+152.9%
alltimeall time+30.3%+175.9%-246.6%+677.3%at high+475.3%

Bellerophon Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2023
-
-$2.17 M(-58.7%)
-$11.03 M(-21.0%)
Jun 2023
-
-$5.26 M(-455.3%)
-$13.95 M(-8.3%)
Mar 2023
-
$1.48 M(-129.1%)
-$15.22 M(-31.8%)
Dec 2022
-$22.32 M(+11.3%)
-$5.08 M(-0.3%)
-$22.32 M(+3.9%)
Sep 2022
-
-$5.09 M(-21.9%)
-$21.49 M(+1.5%)
Jun 2022
-
-$6.52 M(+16.0%)
-$21.17 M(+6.7%)
Mar 2022
-
-$5.62 M(+32.2%)
-$19.85 M(-1.0%)
Dec 2021
-$20.06 M(-23.2%)
-$4.25 M(-11.0%)
-$20.06 M(-16.2%)
Sep 2021
-
-$4.78 M(-8.1%)
-$23.92 M(-12.6%)
Jun 2021
-
-$5.20 M(-10.8%)
-$27.38 M(-1.9%)
Mar 2021
-
-$5.83 M(-28.2%)
-$27.89 M(+6.8%)
Dec 2020
-$26.13 M(+52.6%)
-$8.12 M(-1.4%)
-$26.13 M(+17.5%)
Sep 2020
-
-$8.23 M(+44.0%)
-$22.24 M(+20.1%)
Jun 2020
-
-$5.72 M(+40.7%)
-$18.52 M(+9.3%)
Mar 2020
-
-$4.06 M(-3.9%)
-$16.93 M(-1.1%)
Dec 2019
-$17.13 M(-37.8%)
-$4.23 M(-6.1%)
-$17.13 M(-2.1%)
Sep 2019
-
-$4.50 M(+8.9%)
-$17.49 M(-11.3%)
Jun 2019
-
-$4.14 M(-2.8%)
-$19.73 M(-15.6%)
Mar 2019
-
-$4.25 M(-7.4%)
-$23.37 M(-15.1%)
Dec 2018
-$27.52 M
-$4.59 M(-31.9%)
-$27.52 M(-8.7%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$6.74 M(-13.4%)
-$30.14 M(+2.2%)
Jun 2018
-
-$7.78 M(-7.4%)
-$29.50 M(+5.6%)
Mar 2018
-
-$8.40 M(+16.4%)
-$27.94 M(+15.3%)
Dec 2017
-$24.23 M(+3.7%)
-$7.22 M(+18.5%)
-$24.23 M(+0.1%)
Sep 2017
-
-$6.09 M(-2.2%)
-$24.20 M(+8.9%)
Jun 2017
-
-$6.23 M(+33.0%)
-$22.23 M(+5.6%)
Mar 2017
-
-$4.68 M(-34.9%)
-$21.06 M(-9.9%)
Dec 2016
-$23.36 M(-51.2%)
-$7.19 M(+74.7%)
-$23.36 M(-13.2%)
Sep 2016
-
-$4.12 M(-18.6%)
-$26.92 M(-20.5%)
Jun 2016
-
-$5.06 M(-27.5%)
-$33.88 M(-16.0%)
Mar 2016
-
-$6.99 M(-35.1%)
-$40.34 M(-12.7%)
Dec 2015
-$47.86 M(-19.4%)
-$10.76 M(-2.9%)
-$46.19 M(-4.0%)
Sep 2015
-
-$11.08 M(-3.8%)
-$48.13 M(-8.2%)
Jun 2015
-
-$11.52 M(-10.3%)
-$52.44 M(-9.3%)
Mar 2015
-
-$12.84 M(+1.1%)
-$57.79 M(-2.6%)
Dec 2014
-$59.37 M(-3.6%)
-$12.69 M(-17.6%)
-$59.37 M(-6.4%)
Sep 2014
-
-$15.40 M(-8.7%)
-$63.45 M(+32.0%)
Jun 2014
-
-$16.87 M(+17.1%)
-$48.05 M(+54.1%)
Mar 2014
-
-$14.41 M(-14.1%)
-$31.18 M(+85.9%)
Dec 2013
-$61.57 M(+33.4%)
-$16.77 M
-$16.77 M
Dec 2012
-$46.14 M
-
-

FAQ

  • What is Bellerophon Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual EBITDA year-on-year change?
  • What is Bellerophon Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly EBITDA year-on-year change?
  • What is Bellerophon Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics TTM EBITDA year-on-year change?

What is Bellerophon Therapeutics annual EBITDA?

The current annual EBITDA of BLPH is -$22.32 M

What is the all time high annual EBITDA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual EBITDA is -$17.13 M

What is Bellerophon Therapeutics annual EBITDA year-on-year change?

Over the past year, BLPH annual EBITDA has changed by -$2.26 M (-11.27%)

What is Bellerophon Therapeutics quarterly EBITDA?

The current quarterly EBITDA of BLPH is -$2.17 M

What is the all time high quarterly EBITDA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly EBITDA is $1.48 M

What is Bellerophon Therapeutics quarterly EBITDA year-on-year change?

Over the past year, BLPH quarterly EBITDA has changed by +$2.92 M (+57.41%)

What is Bellerophon Therapeutics TTM EBITDA?

The current TTM EBITDA of BLPH is -$11.03 M

What is the all time high TTM EBITDA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high TTM EBITDA is -$11.03 M

What is Bellerophon Therapeutics TTM EBITDA year-on-year change?

Over the past year, BLPH TTM EBITDA has changed by +$10.46 M (+48.68%)